ArkVax Seed
2 known investors
ArkVax develops glycoconjugate vaccines for animal health using genetic engineering of bacterial cells, aiming to provide broader protection than current vaccines. Its technology targets antibacterial and zoonotic diseases to help combat antimicrobial resistance in both livestock and humans.
Founders & leadership
JC
Jon CuccuiinFounder
Investors · 2
Frequently asked questions
- What does ArkVax Seed do?
- ArkVax develops glycoconjugate vaccines for animal health using genetic engineering of bacterial cells, aiming to provide broader protection than current vaccines. Its technology targets antibacterial and zoonotic diseases to help combat antimicrobial resistance in both livestock and humans.
- Who founded ArkVax Seed?
- ArkVax Seed was founded by Jon Cuccui.
- Who are ArkVax Seed's investors?
- ArkVax Seed's investors include Future Planet Capital, UK Innovation & Science Seed Fund.